Shanxi Zhendong Pharmaceutical (300158) - Total Assets

Latest as of September 2025: CN¥4.51 Billion CNY ≈ $660.15 Million USD

Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) holds total assets worth CN¥4.51 Billion CNY (≈ $660.15 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 300158 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Shanxi Zhendong Pharmaceutical - Total Assets Trend (2007–2024)

This chart illustrates how Shanxi Zhendong Pharmaceutical's total assets have evolved over time, based on quarterly financial data. See Shanxi Zhendong Pharmaceutical net assets for net asset value and shareholders' equity analysis.

Shanxi Zhendong Pharmaceutical - Asset Composition Analysis

Current Asset Composition (December 2024)

Shanxi Zhendong Pharmaceutical's total assets of CN¥4.51 Billion consist of 64.5% current assets and 35.5% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	11.7%
Accounts Receivable	CN¥775.81 Million	15.6%
Inventory	CN¥775.98 Million	15.6%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥371.90 Million	7.5%
Goodwill	CN¥15.50 Million	0.3%

Asset Composition Trend (2007–2024)

This chart illustrates how Shanxi Zhendong Pharmaceutical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Shanxi Zhendong Pharmaceutical.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Shanxi Zhendong Pharmaceutical's current assets represent 64.5% of total assets in 2024, an increase from 46.0% in 2007.
Cash Position: Cash and equivalents constituted 11.7% of total assets in 2024, up from 7.0% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 15.0% in 2007.
Asset Diversification: The largest asset category is inventory at 15.6% of total assets.

Shanxi Zhendong Pharmaceutical Competitors by Total Assets

Key competitors of Shanxi Zhendong Pharmaceutical based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Shanxi Zhendong Pharmaceutical - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.14	5.40	2.24
Quick Ratio	2.35	3.91	1.75
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.80 Billion	CN¥3.22 Billion	CN¥2.11 Billion

Shanxi Zhendong Pharmaceutical - Advanced Valuation Insights

This section examines the relationship between Shanxi Zhendong Pharmaceutical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.74
Latest Market Cap to Assets Ratio	0.14
Asset Growth Rate (YoY)	-19.4%
Total Assets	CN¥4.98 Billion
Market Capitalization	$721.67 Million USD

Valuation Analysis

Below Book Valuation: The market values Shanxi Zhendong Pharmaceutical's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Shanxi Zhendong Pharmaceutical's assets decreased by 19.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Shanxi Zhendong Pharmaceutical (2007–2024)

The table below shows the annual total assets of Shanxi Zhendong Pharmaceutical from 2007 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥4.98 Billion ≈ $729.13 Million	-19.38%
2023-12-31	CN¥6.18 Billion ≈ $904.40 Million	-5.65%
2022-12-31	CN¥6.55 Billion ≈ $958.60 Million	-35.10%
2021-12-31	CN¥10.09 Billion ≈ $1.48 Billion	+32.75%
2020-12-31	CN¥7.60 Billion ≈ $1.11 Billion	+9.95%
2019-12-31	CN¥6.92 Billion ≈ $1.01 Billion	-4.12%
2018-12-31	CN¥7.21 Billion ≈ $1.06 Billion	-5.27%
2017-12-31	CN¥7.61 Billion ≈ $1.11 Billion	+10.75%
2016-12-31	CN¥6.87 Billion ≈ $1.01 Billion	+68.89%
2015-12-31	CN¥4.07 Billion ≈ $595.64 Million	+42.41%
2014-12-31	CN¥2.86 Billion ≈ $418.26 Million	+2.20%
2013-12-31	CN¥2.80 Billion ≈ $409.27 Million	+8.25%
2012-12-31	CN¥2.58 Billion ≈ $378.09 Million	+14.54%
2011-12-31	CN¥2.26 Billion ≈ $330.10 Million	+3.93%
2010-12-31	CN¥2.17 Billion ≈ $317.61 Million	+237.46%
2009-12-31	CN¥643.18 Million ≈ $94.12 Million	+29.49%
2008-12-31	CN¥496.69 Million ≈ $72.68 Million	+6.43%
2007-12-31	CN¥466.70 Million ≈ $68.29 Million	--

About Shanxi Zhendong Pharmaceutical

SHE:300158 China Drug Manufacturers - Specialty & Generic

Market Cap

$721.67 Million

CN¥4.93 Billion CNY

Market Cap Rank

#10249 Global

#2689 in China

Share Price

CN¥4.97

Change (1 day)

+0.81%

52-Week Range

CN¥4.57 - CN¥9.45

All Time High

CN¥12.00